Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen (Q73764231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

metastatic renal cell carcinoma

1 reference

S S Chang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V E Reuter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

W D Heston

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P B Gaudin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

801-805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

ProstaScint scan may enhance identification of prostate cancer recurrences after prostatectomy, radiation, or hormone therapy: analysis of 136 scans of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Indium-111 capromab pendetide (ProstaScint) imaging to detect recurrent and metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

Angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

111Indium-capromab pendetide unexpectedly localizes to renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901094-3

7 January 2021

10.1016/S0090-4295(00)01094-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11306418%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference